Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Ucb Pharma Gmbh patents

Recent patent applications related to Ucb Pharma Gmbh. Ucb Pharma Gmbh is listed as an Agent/Assignee. Note: Ucb Pharma Gmbh may have other listings under different names/spellings. We're not affiliated with Ucb Pharma Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Ucb Pharma Gmbh-related inventors

Use of rotigotine for treating the restless leg syndrome

This invention relates to the use of rotigotine for the effective treatment of Restless Leg Syndrome (RLS) as well as to a rotigotine-containing transepicutaneous pharmaceutical composition, provided in particular in the form of an acrylate- or silicone-based Transdermal Therapeutic System (US) having a surface area of 2.5 to 20 cm2... Ucb Pharma Gmbh

Transdermal delivery system containing rotigotine

Transdermal therapeutic system for the transdermal administration of rotigotine containing an therapeutically effective amount of rotigotine base in a self-adhesive layer structure, comprising A) a backing layer, and B) a rotigotine-containing biphasic layer, the bi phasic layer having a) an outer phase having a composition comprising 75% to 100% of... Ucb Pharma Gmbh

Method for adjusting the release of active agent in a transdermal delivery system

Use of an additive in a transdermal therapeutic system with an active agent-containing layer in the form of a biphasic layer having a hydrophilic inner phase and a hydrophobic outer phase, wherein the inner phase comprises the additive and an active agent dissolved therein, wherein the additive has a higher... Ucb Pharma Gmbh

Pharmaceutical composition comprising lacosamide and levetiracetam

The present application relates to a fixed dose combination comprising lacosamide and levetiracetam, as well as to dosage regimens including such fixed dose combinations. The fixed dose combinations are suitable for the oral or parenteral treatment of various diseases, including in particular epilepsy and/or epileptic seizures.... Ucb Pharma Gmbh

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Ucb Pharma Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ucb Pharma Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by